.svg){kind=small}
Discover opportunities months before the RFP drops
Learn more →Discover opportunities months before the RFP drops
Learn more →Retrieving RFP details
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis
The Department of Veterans Affairs (VISN 1 / Network Contracting Office) seeks a contractor to provide radiopharmaceutical products for the VA Manchester Healthcare System. This sole-source special notice requires an NRC-licensed contractor to supply nuclear medicine and PET products with daily delivery capabilities. The period of performance for this procurement is from December 1, 2025, to November 30, 2026.
Starbridge can help you:
Pain points mentioned in board meetings and strategic plans
Instantly outline and draft all requirements
Bring in your USPs and exploit competitor gaps
Starbridge can help you:
Get ahead of RFPs — target accounts planning budget or ending contracts soon
Accounts with contract expirations, meetings mentioning your product, grants, budget changes and more
Starbridge.ai books 30 - 40% of leads into meetings
No files attached to this RFP.
Many agencies add documentation later or require FOIA requests. Starbridge can automatically retrieve these files for you.
The VA Network Contracting Office 22 issued a Sources Sought/RFI (36C26226Q0243) to gather market information to establish a single-award IDIQ for multiple radiopharmaceuticals to serve VA Phoenix and VA Tucson Healthcare Systems. Responses including capabilities, SAM.gov Unique Entity ID/CAGE code and market-pricing information are requested for planning purposes and must be emailed to Hestia.Sim@va.gov by Jan 13, 2026 at 10:00 AM Pacific. The notice requires NRC licensure and compliance with DOT, FDA, OSHA and other federal/state regulations and specifies daily ordering and next-business-day delivery requirements to the listed VAMCs.
Posted Date
Jan 6, 2026
Due Date
Jan 13, 2026
Release: Jan 6, 2026
Close: Jan 13, 2026
The VA Network Contracting Office 22 issued a Sources Sought/RFI (36C26226Q0243) to gather market information to establish a single-award IDIQ for multiple radiopharmaceuticals to serve VA Phoenix and VA Tucson Healthcare Systems. Responses including capabilities, SAM.gov Unique Entity ID/CAGE code and market-pricing information are requested for planning purposes and must be emailed to Hestia.Sim@va.gov by Jan 13, 2026 at 10:00 AM Pacific. The notice requires NRC licensure and compliance with DOT, FDA, OSHA and other federal/state regulations and specifies daily ordering and next-business-day delivery requirements to the listed VAMCs.
AvailableThe U.S. Department of Veterans Affairs is soliciting proposals to supply Ustekinumab pens/syringes or an FDA-licensed biosimilar to support VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center requirements. The contract term is one year with four pre-priced one-year option periods and requires the contractor to provide an uninterrupted source of supply and have a unique NDC label. Estimated annual requirements are listed (2,917 units of Ustekinumab 5mg/mL; 9,608 units of Ustekinumab 45mg/0.5mL; 45,763 units of Ustekinumab 90mg/mL).
Posted Date
Dec 11, 2025
Due Date
Mar 20, 2026
Release: Dec 11, 2025
Close: Mar 20, 2026
The U.S. Department of Veterans Affairs is soliciting proposals to supply Ustekinumab pens/syringes or an FDA-licensed biosimilar to support VA, Department of Defense, Bureau of Prisons, Indian Health Service, and Federal Health Care Center requirements. The contract term is one year with four pre-priced one-year option periods and requires the contractor to provide an uninterrupted source of supply and have a unique NDC label. Estimated annual requirements are listed (2,917 units of Ustekinumab 5mg/mL; 9,608 units of Ustekinumab 45mg/0.5mL; 45,763 units of Ustekinumab 90mg/mL).
The VA National Acquisition Center intends to issue RFP 36E79726R0004 for an unrestricted procurement of Buprenorphine HCL/Naloxone HCL tablets to supply the Department of Veterans Affairs and other federal customers (DOD, BOP, IHS). The award will be a single contract for one year plus four one-year option periods, with distribution through VA and DOD Pharmaceutical Prime Vendor Programs and specific packaging/NDC requirements. The solicitation was published 2025-12-31 and has a tentative electronic issue date about 2026-01-05 with a response/closing date of 2026-01-19.
Posted Date
Dec 31, 2025
Due Date
Jan 19, 2026
Release: Dec 31, 2025
Close: Jan 19, 2026
The VA National Acquisition Center intends to issue RFP 36E79726R0004 for an unrestricted procurement of Buprenorphine HCL/Naloxone HCL tablets to supply the Department of Veterans Affairs and other federal customers (DOD, BOP, IHS). The award will be a single contract for one year plus four one-year option periods, with distribution through VA and DOD Pharmaceutical Prime Vendor Programs and specific packaging/NDC requirements. The solicitation was published 2025-12-31 and has a tentative electronic issue date about 2026-01-05 with a response/closing date of 2026-01-19.
The VA National Acquisition Center (NAC) intends to issue RFP 36E79726R0004 for Buprenorphine HCL/Naloxone HCL tablets to supply the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The award will be a single contract to a responsible offeror to provide uninterrupted supply, for a base period of one year plus four pre-priced one-year option periods, with distribution through the VA’s and DOD’s Pharmaceutical Prime Vendor Programs. The solicitation was to be electronically issued on or about 2026-01-05 with a tentative closing (response) date of 2026-01-19; estimated annual requirements and formulation sizes are listed in the posting.
Posted Date
Jan 5, 2026
Due Date
Jan 19, 2026
Release: Jan 5, 2026
Close: Jan 19, 2026
The VA National Acquisition Center (NAC) intends to issue RFP 36E79726R0004 for Buprenorphine HCL/Naloxone HCL tablets to supply the Department of Veterans Affairs, Department of Defense, Bureau of Prisons, and Indian Health Service. The award will be a single contract to a responsible offeror to provide uninterrupted supply, for a base period of one year plus four pre-priced one-year option periods, with distribution through the VA’s and DOD’s Pharmaceutical Prime Vendor Programs. The solicitation was to be electronically issued on or about 2026-01-05 with a tentative closing (response) date of 2026-01-19; estimated annual requirements and formulation sizes are listed in the posting.
Surface intent from meeting minutes, budgets, and contract expirations. Influence RFP requirements before competitors ever see them.
See your top 10 upcoming opportunities on a demo →Premium
Access the largest public sector contact database
Premium
Get complete source documentation & analysis